RFICs

WHITE PAPERS AND CASE STUDIES

• Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches

  Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).

• Innovating The mAb Characterization Process

  Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.

• Generation Of A Contamination Control Strategy

  An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.

• How Can You Avoid Bioprocessing Risks When Using Cable Ties?

  Cable ties in bioprocessing can cause leaks, damage, and delays. See how switching to a uniform-sealing connector can significantly improve efficiency, reduce prep time, and minimize contamination risks.

• How A Leading CDMO Reduced Yield Variability With Automation

  Explore the transformative journey of a leading CDMO company and how they adopted an innovative platform that enhances data analytics and drives pharmaceutical manufacturing advancements.

• Successful Completion Of The Project NaDiNa

  Conducted alongside the Faculty of Medicine at Palacky University and supported by the Technology Agency of the Czech Republic, this project focused on translating research into a viable medicinal product.

• Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments

  Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

• Navigating Sensitive Country Requirements

  See how Scout expertly navigated complex regional laws and regulations to allow study patients in Iran access to treatment in Turkey.

• CRO Takes Trial Build Times From Weeks To Days

  Recognizing the inefficiencies in traditional build processes, a top global CRO partnered with Medable to transform its approach to clinical trial launch.

• Time-To-Manufacture Reduced By 30% Through Rapid Transfer Strategy

  Critical formulation deficiencies were solved through rapid batch manufacturing and process adjustments. This enabled a 30% reduction in time-to-manufacture and prevented delays to the start date.

• Cell Therapy Facility For DTM At NIH Clinical Center

  Discover how Germfree maximized available space and met cGMP cleanroom standards with a state-of-the-art modular cell therapy facility for the NIH, advancing treatments for serious medical conditions.

• Supporting A CAR T-Cell Therapy Study In Hematologic Malignancies

  To address a life-threatening complication of immunotherapy in hematologic malignancies, a U.S. biotech company developed a novel compound.